10X Genomics Inc (TXG) — Cash Flow Reinvestment Rate
10X Genomics Inc (TXG) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting $9.49 Million (capex $687.00K plus investments $-8.80 Million) from operating cash flow of $43.21 Million. Check earnings quality score of 10X Genomics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
10X Genomics Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for 10X Genomics Inc across 2 annual periods. Explore 10X Genomics Inc (TXG) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for 10X Genomics Inc (2019–2024)
Year-by-year capital reinvestment analysis for 10X Genomics Inc. For live market cap and broader valuation context, see 10X Genomics Inc (TXG) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 6.76x | $45.02 Million | $6.66 Million | $12.39 Million | ▲ +173.5% |
| 2019 | 2.47x | $85.53 Million | $34.63 Million | $42.77 Million | — |